LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations

被引:91
作者
Li, Yongsheng [1 ,2 ]
Li, Lili [1 ]
Wang, Zishan [1 ]
Pan, Tao [1 ]
Sahni, Nidhi [2 ]
Jin, Xiyun [1 ]
Wang, Guangjuan [1 ]
Li, Junyi [1 ]
Zheng, Xiangyi [1 ]
Zhang, Yunpeng [1 ]
Xu, Juan [1 ]
Yi, Song [2 ]
Li, Xia [1 ]
机构
[1] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Heilongjiang, Peoples R China
[2] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
基金
中国国家自然科学基金; 中国博士后科学基金; 国家高技术研究发展计划(863计划);
关键词
FACTOR REGULATORY NETWORKS; GENE; GENOME; LNCRNA; DATABASE; EXPRESSION; REVEALS; IDENTIFICATION; METHYLATION; METASTASIS;
D O I
10.1093/nar/gkx1311
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gene regulatory network perturbations contribute to the development and progression of cancer, however, molecular determinants that mediate transcriptional perturbations remain a fundamental challenge for cancer biology. We show that transcriptional perturbations are widely mediated by long noncoding RNAs (lncRNAs) via integration of genome-wide transcriptional regulation with paired lncRNA and gene expression profiles. Systematic construction of an LncRNA Modulator Atlas in Pan-cancer (LncMAP) reveals distinct types of lncRNA regulatory molecules, which are expressed in multiple tissues, exhibit higher conservation. Strikingly, cancers with similar tissue origin share lncRNA modulators which perturb the regulation of cell cycle and immune response-related functions. Furthermore, we identified a large number of pan-cancer lncRNA modulators with potential clinical significance, which are differentially expressed in cancer or are strongly correlated with drug sensitivity across cell lines. Further stratification of cancer patients based on lncRNA-mediated transcriptional perturbations identifies subtypes with distinct survival rates. Finally, we made a user-friendly web interface available for exploring lncRNA-mediated transcriptional perturbations across cancer types. Our study provides a systems-level dissection of lncRNA-mediated regulatory perturbations in cancer, and also presents a valuable tool and resource for investigating the function of lncRNAs in cancer.
引用
收藏
页码:1113 / 1123
页数:11
相关论文
共 63 条
[1]   Immunity, inflammation and cancer: a leading role for adenosine [J].
Antonioli, Luca ;
Blandizzi, Corrado ;
Pacher, Pal ;
Hasko, Gyoergy .
NATURE REVIEWS CANCER, 2013, 13 (12) :842-857
[2]   RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas [J].
Bao, Zhao-Shi ;
Chen, Hui-Min ;
Yang, Ming-Yu ;
Zhang, Chuan-Bao ;
Yu, Kai ;
Ye, Wan-Lu ;
Hu, Bo-Qiang ;
Yan, Wei ;
Zhang, Wei ;
Akers, Johnny ;
Ramakrishnan, Valya ;
Li, Jie ;
Carter, Bob ;
Liu, Yan-Wei ;
Hu, Hui-Min ;
Wang, Zheng ;
Li, Ming-Yang ;
Yao, Kun ;
Qiu, Xiao-Guang ;
Kang, Chun-Sheng ;
You, Yong-Ping ;
Fan, Xiao-Long ;
Song, Wei Sonya ;
Li, Rui-Qiang ;
Su, Xiao-Dong ;
Chen, Clark C. ;
Jiang, Tao .
GENOME RESEARCH, 2014, 24 (11) :1765-1773
[3]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[4]   Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group [J].
Beckers, Thomas ;
Burkhardt, Carmen ;
Wieland, Heike ;
Gimmnich, Petra ;
Ciossek, Thomas ;
Maier, Thomas ;
Sanders, Karl .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (05) :1138-1148
[5]   ImmPort: disseminating data to the public for the future of immunology [J].
Bhattacharya, Sanchita ;
Andorf, Sandra ;
Gomes, Linda ;
Dunn, Patrick ;
Schaefer, Henry ;
Pontius, Joan ;
Berger, Patty ;
Desborough, Vince ;
Smith, Tom ;
Campbell, John ;
Thomson, Elizabeth ;
Monteiro, Ruth ;
Guimaraes, Patricia ;
Walters, Bryan ;
Wiser, Jeff ;
Butte, Atul J. .
IMMUNOLOGIC RESEARCH, 2014, 58 (2-3) :234-239
[6]   Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses [J].
Cabili, Moran N. ;
Trapnell, Cole ;
Goff, Loyal ;
Koziol, Magdalena ;
Tazon-Vega, Barbara ;
Regev, Aviv ;
Rinn, John L. .
GENES & DEVELOPMENT, 2011, 25 (18) :1915-1927
[7]   LncRNADisease: a database for long-non-coding RNA-associated diseases [J].
Chen, Geng ;
Wang, Ziyun ;
Wang, Dongqing ;
Qiu, Chengxiang ;
Liu, Mingxi ;
Chen, Xing ;
Zhang, Qipeng ;
Yan, Guiying ;
Cui, Qinghua .
NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) :D983-D986
[8]   Long non-coding RNA PVT1 and cancer [J].
Cui, Ming ;
You, Lei ;
Ren, Xiaoxia ;
Zhao, Wenjing ;
Liao, Quan ;
Zhao, Yupei .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 471 (01) :10-14
[9]   Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53 [J].
Dixit, Updesh ;
Liu, Zhihe ;
Pandey, Ashutosh K. ;
Kothari, Ramesh ;
Pandey, Virendra N. .
BMC CANCER, 2014, 14
[10]   Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders [J].
Falkenberg, Katrina J. ;
Johnstone, Ricky W. .
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (09) :673-691